Home / Market News / $SGP

$SGP news and market catalysts

The 3 most recent market catalysts affecting $SGP, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 1 high impact 0 bullish 0 bearish Pharmaceuticals
Oct 5, 2026 Corporate Catalyst Neutral Impact 55
HC Wainwright & Co. Reiterates Buy on SpyGlass Pharma, Maintains $37 Price Target
HC Wainwright & Co. analyst Yi Chen has reaffirmed a 'Buy' rating and a $37 price target for SpyGlass Pharma (SGP). This action signals that the analyst's fundamental outlook on th…
Oct 1, 2026 Corporate Catalyst Neutral Impact 85
SpyGlass Pharma Acquires Advanced Vision Science For ~$13M In Cash
SpyGlass Pharma (SGP) has acquired Advanced Vision Science (AVS) for $13 million in cash. This is a significant strategic move for SGP as AVS is currently the manufacturer of SGP's…
Aug 14, 2026 Corporate Catalyst Neutral Impact 65
Raymond James Initiates Coverage On SpyGlass Pharma with Outperform Rating, Announces Price Target of $39
Raymond James analyst Christopher Raymond has initiated coverage on SpyGlass Pharma (SGP) with an 'Outperform' rating and a $39 price target. This event is significant as it marks …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.